Skip to main content

Table 1 Baseline demographic and clinical characteristics

From: Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy

Characteristic Total
(N = 810)
Female sex – no. (%) 305 (38)
Age – years  
   Mean (SD) 69 (10)
Patients fulfilling inclusion criteria – no. (%)  
   Recent creatinine >1.5 mg/dL 148 (18)
   Diabetes mellitus 458 (57)
   Heart failure 105 (13)
   Shock 2 (0.2)
   Aged >70 years 458 (57)
History of hypertension – no. (%) 659 (81.4)
Serum creatinine – mg/dL  
   Median (IQR) 1.1 (0.5)
Estimated creatinine clearance* – mL/kg/min  
   Median (IQR) 60 (38)
  1. SD, standard deviation; IQR, interquartile range.
  2. * Creatinine clearance estimated by the Cockcroft-Gault formula.